UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
ZOGENIX, INC.
(Name of Subject Company)
ZOGENIX, INC.
(Name of Person Filing Statement)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
98978L204
(CUSIP Number of Class of Securities)
Stephen J. Farr, Ph.D.
President and Chief Executive Officer
Zogenix, Inc.
5959 Horton Street, Suite 500
Emeryville, CA 94608
(510) 550-8300
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on
Behalf of the Person Filing Statement)
With copies to:
Scott Shean
Latham & Watkins LLP
650 Town Center Dr
20th Floor
Costa Mesa, CA 92626
Telephone: (714) 540-1235
☒ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
The information set forth under Items 1.01, 7.01 and 9.01 of the Current Report on Form 8-K filed by Zogenix, Inc. (the Company or Zogenix) on January 19, 2022 (including all exhibits attached thereto and incorporated therein by reference) is incorporated herein by reference.